# Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402

> **NCT03921268** · PHASE1 · COMPLETED · sponsor: **AstraZeneca** · enrollment: 18 (actual)

## Conditions studied

- Asthma

## Interventions

- **DRUG:** AZD1402

## Key facts

- **NCT ID:** NCT03921268
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-25
- **Primary completion:** 2019-06-13
- **Final completion:** 2019-06-13
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2019-06-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03921268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03921268, "Study to Assess Effect of Device and Formulation on Pharmacokinetics (PK) of AZD1402". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03921268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*